Menu

Phase I/Investigational Therapeutics Program

Phase I Team The Phase I/Investigational Therapeutics Program is a multidisciplinary scientific group designed to develop new methods for the treatment of cancer. The program includes a team of medical oncologists, nurses, research scientists, data coordinators and social workers who have extensive experience in providing novel therapeutic strategies. The program conducts trials of novel targeted therapy approaches, including genomics-directed protocols, and novel immuno-oncology approaches, as well as first in human trials of novel compounds. Clinical trial offerings are diverse and include partnerships with academia, industry, and government. 

Through this program, patients and physicians have access to the newest and the most promising cancer treatments supported by the National Cancer Institute, pharmaceutical companies and the Rutgers Cancer Institute. Patients with a variety of cancers are typically eligible to receive these new treatment options. Patients may have received multiple types of prior therapies or even occasionally, are referred for treatment prior to receiving any anticancer therapies. The Phase I team meets weekly to discuss current and pending clinical trials, and reviews all patients on Phase I clinical trials.

 

Clinical Trials:

Staff of this Program:

Janice Mehnert, MD, Director, Phase I and Investigational Therapeutics Program, and Medical Oncologist
Nancy Chan, MD, Medical Oncologist
Eugenia Girda, MD, FACOG, Gynecologic Oncologist
Jyoti Malhotra, MD, MPH, Medical Oncologist
Usha Malhotra, MD, Medical Oncologist
Ann Silk, MD, Medical Oncologist
Kristen Spencer, DO, MPH, Medical Oncologist
Mark Coogan, Advanced Practice Nurse
Jacqui Norrell, Advanced Practice Nurse
Alyssa Iwano, Research Nurse Clinician
Debbie Pomponio, Research Nurse Clinician
Melissa Frankel, Research Nurse Clinician
Demmie Aguilar, Research Coordinator
Rebecca St. Fort, Research Coordinator
John De Prima, Research Coordinator
Aparna Kareddula, Research Coordinator
Daniela Portal, Data Manger
Veeraswamy Manne, Writing and Protocol Support
Joanne Onyscak, Program Manager

 

 

precision medicine at Rutgers Cancer Institute

 

 

 

ScreenNJ

 

 

Donate Now

 

 

 


 

 

 

 

Proud member of
Big Ten Cancer Research Consortium

 

 

Rutgers Health